From: Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis
Genetic | Identification of pathogenic mutations of TSC1 or TSC2 in DNA from healthy tissue is sufficient to establish a definitive diagnosis of tuberous sclerosis complex | |
---|---|---|
Clinical | Major | Minor |
Hypomelanotic macules (≥ 3, at least 5 mm in diameter) | Confetti-like skin lesions | |
Angiofibromas (≥ 3) or fibrous cephalic plaque | Pitted teeth (> 3) | |
Ungual fibromas (≥ 2) | Intraoral fibromas | |
Shagreen patch | Retinal achromic patch | |
Multiple retinal hamartomas | Multiple renal cysts | |
Cortical dysplasia* | Extra-renal hamartomas | |
Subependymal nodules | ||
Subependymal giant cell astrocytoma | ||
Cardiac rhabdomyomas | ||
Lymphangioleiomyomatosis (LAM)** | ||
Angiomyolipoma (≥ 2)** | ||
Definitive diagnosis: | 2 major criteria or 1 major criterion + ≥ 2 minor criteria | |
Possible diagnosis | 1 major criterion or ≥ 2 minor criteria |